SCHEMBL8340939

SCHEMBL8340939

CN(C)c1cc(Nc2cccc(O)c2)nc(N2CCN(Cc3ccsc3)CC2)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.41
KMT2A Q03164 1/20 0.39
DRD2 P14416 2/20 0.39
DRD3 P35462 2/20 0.39
DRD4 P21917 1/20 0.39
PIK3CA P42336 7/20 0.38
ALDH1A1 P00352 1/20 0.38
OPRM1 P35372 1/20 0.38
OPRD1 P41143 1/20 0.38
OPRK1 P41145 1/20 0.38
BCL2L1 Q07817 1/20 0.37
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
FGFR3 P22607 1/20 0.36
CYP2C19 P33261 1/20 0.36
PIK3CD O00329 1/20 0.35
PIK3CB P42338 1/20 0.35
PIK3CG P48736 1/20 0.35
GALR2 O43603 1/20 0.35
GALR1 P47211 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3236256 0.88 DRD2 (0.48) HTR2AKMT2ADRD2DRD3DRD4
SCHEMBL3240312 0.88 GALR2 (0.50) HTR2ADRD2DRD3DRD4ALDH1A1
SCHEMBL3241396 0.85 LMNA (0.43) DRD2DRD3DRD4ALDH1A1CYP1A2
SCHEMBL6788475 0.78 CASP1 (0.45) HTR2AALDH1A1GALR2GALR1LMNA
SCHEMBL6789057 0.78 LMNA (0.51) GPR6LMNA
SCHEMBL6790565 0.77 KDM4E (0.50) HTR2AKMT2ADRD2DRD3DRD4
SCHEMBL6791198 0.76 CASP1 (0.57) HTR2AKMT2ADRD2DRD3DRD4
SCHEMBL8254499 0.76 CASP1 (0.43) HTR2AALDH1A1GALR2GALR1LMNA
SCHEMBL6788494 0.76 KDM4E (0.48) HTR2AKMT2AALDH1A1GALR2GALR1
SCHEMBL6797121 0.75 GALR2 (0.54) HTR2ADRD2DRD3DRD4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004014376-A1 GAL3 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF AFFECTIVE DISORDERS SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2004-02-19 WO disclosed